ArticleBreast cancer research and treatment2025

Pooled clinical trial analyses evaluating outcomes of HER2-low vs HER2-0 expression in patients with metastatic breast cancer following chemotherapy.

Elizabeth B Lamont et al.PubMed ↗Publisher ↗

No numbers read from the abstract.